Glen D. Stettin, Senior VP, Clin. Res. & New Sol at Express Scripts Holding Co. (ESRX), sold 30,631 shares at $88.35 ($2.7M) on 2015-02-24, disclosed to the SEC on 2015-02-26.
Scheduled sale ($2.7M) by Senior VP, Clin. Res. & New Sol under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.68 | 4,200 | $364K | 13.6% |
| 2 | $87.55 | 11,039 | $966K | 36.0% |
| 3 | $87.62 | 3,028 | $265K | 9.9% |
| 4 | $88.35 | 6,500 | $574K | 21.4% |
| 5 | $87.31 | 5,864 | $512K | 19.1% |
| Total | $87.56 avg | 30,631 |
| $2.7M |
| 100% |
| Filing → |
| ESRX | SELL | 2015-03-03 | $226K | — | Filing → |
| ESRX | SELL | 2014-12-01 | $896K | — | Filing → |
| ESRX | SELL | 2014-11-25 | $886K | — | Filing → |